Evidence Synthesis
Radaan Laboratories Limited (RADAAN) witnessed a decline in its quarterly gross margin, accelerating to -43.01%, up from -26.41%.
The company's marginal operating leverage also accelerated, reaching , up from -88.71%. However, its revenue growth year-over-year declined, falling to . On the trading front, RADAAN's price decreased, moving from 3 INR to () in a single day. Additionally, the daily trading volume decreased, moving from 29316 shares to (-0.505).
By paying you agree to our Terms and Privacy Policy.